News

Unilateral ptosis can be the first symptom related to other causes that are traumatic, myogenic, neurogenic, or mechanical in nature.

Investigators at Dartmouth College have found that eye contact during a conversation makes the discussion more appealing to its participants.

Pilot study shows promise of teaching surgeons with technology.

Lisa Nijm, MD, JD, discusses the brand-new Real World Ophthalmology conference, designed to support ophthalmologists starting practice.

Speed the return to baseline visual acuity—and make your patients happy.

Children’s Hospital of Philadelphia and Stanford University School of Medicine will lead the $5.4 million study ,with patient recruitment beginning in late 2021 or early 2022.

AbbVie and REGENXBIO announced a strategic partnership to develop and commercialize RGX-314, an investigational gene therapy for wet age-related macular degeneration, diabetic retinopathy and other chronic retinal diseases.

CXL is safe, effective to perform on younger population, study results show.

Marta Belmonte-Grau, MD discusses the potential risk for posterior capsular rupture during cataract surgery.

A case study details the care of a patient who had already lost vision in one eye from a similar issue.

A 48-year-old male patient presented to an ophthalmic emergency department with what was described as progressive bilateral corneal melting 5 weeks after he received the first dose of a COVID-19 vaccine.

Despite varied results, the company will submit a New Drug Application for pegcetacoplan for geographic atrophy to the FDA early next year.

José-Alain Sahel, MD, explains how optogenetics involves artificial photoreceptors from specific retinal cells to restore vision.

The new virtual conference will debut on Sept. 18, and can help young ophthalmologists solve the small problems before they become bigger problems.

Horizon Therapeutics announced Tuesday the enrollment of the first patient in its Phase 4 clinical trial analyzing TEPEZZA® for the treatment of thyroid eye disease.

OD-OS’s teleguidance offering addresses the lack of experts and also benefits teaching in retina laser care.

Rhegmatogenous retinal detachment studied.

The gene-based AAVCOVID vaccine employs a unique adeno-associated viral vector technology that was shown in non-clinical, nonhuman primate studies to enable protection from SARS-CoV-2 challenge and to induce sustained antibody and cellular immune responses from a single dose for up to a year.

Why instillation of topical corticosteroids may be associated with greater ptosis and higher rate of failed ptosis repair

TearClear to start clinical trial for TC-002 latanoprost ophthalmic solution 0.005%.

Early experience with next-generation lens engenders positive perception.

A study in the United Arab Emirates reported a possible link between adverse ocular events and a COVID-19 vaccination.

Researchers believe the vial has the potential to transform the way corneal grafts are preserved and will provide scientists with a platform to develop customized preservation solutions.

Development of new animal model enhances study of potential mutations.

Scanning laser ophthalmoscopy offers improved view of posterior segment.

Check out the latest cartoon!

Amid a surging COVID-19 pandemic, ophthalmologists in the path of Hurricane Ida are now dealing with the storm's impact.

Reports indicate the variant was first detected in Colombia in early 2021 and has currently spread to 39 countries including the United States.